Catalog Home Page

Publications: Phillips, Elizabeth

Stats for Phillips, Elizabeth
Export as [feed] RSS
Group by: Publication Type | Year
Number of items: 291.

Journal Article

Trubiano, J.A., Stone, C.A., Grayson, M.L., Urbancic, K., Slavin, M.A., Thursky, K.A. and Phillips, E.J. (2017) The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Pavlos, R., Redwood, A. and Phillips, E. (2017) AdDRESSing T-cell responses to antituberculous drugs. British Journal of Dermatology, 176 (2). pp. 292-293.

Thomas, M., Hopkins, C., Duffy, E., Lee, D., Loulergue, P., Ripamonti, D., Ostrov, D.A. and Phillips, E. (2017) Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Clinical Infectious Diseases, 64 (9). pp. 1198-1203.

Tseng, A., Hughes, C.A., Wu, J., Seet, J. and Phillips, E.J. (2017) Cobicistat Versus Ritonavir: Similar pharmacokinetic enhancers but some important differences. Annals of Pharmacotherapy, 51 (11). pp. 1008-1022.

Karnes, J.H., Shaffer, C.M., Bastarache, L., Gaudieri, S., Glazer, A.M., Steiner, H.E., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Comparison of HLA allelic imputation programs. PLoS ONE, 12 (2).

Abana, C.O., Pilkinton, M.A., Gaudieri, S., Chopra, A., McDonnell, W.J., Wanjalla, C., Barnett, L., Gangula, R., Hager, C., Jung, D.K., Engelhardt, B.G., Jagasia, M.H., Klenerman, P., Phillips, E.J., Koelle, D.M., Kalams, S.A. and Mallal, S.A. (2017) Cytomegalovirus (CMV) Epitope–Specific CD4 + T Cells Are Inflated in HIV + CMV + Subjects. The Journal of Immunology, 199 (9). pp. 3187-3201.

da Silva Antunes, R., Paul, S., Sidney, J., Weiskopf, D., Dan, J.M., Phillips, E., Mallal, S., Crotty, S., Sette, A. and Lindestam Arlehamn, C.S. (2017) Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect Ex Vivo tetanus CD4+ T cell responses. PLoS ONE, 12 (1).

Somogyi, A.A. and Phillips, E. (2017) Genomic testing as a tool to optimise drug therapy. Australian Prescriber, 40 (3). pp. 101-104.

Grifoni, A., Angelo, M.A., Lopez, B., O’Rourke, P.H., Sidney, J., Cerpas, C., Balmaseda, A., Silveira, C.G.T., Maestri, A., Costa, P.R., Durbin, A.P., Diehl, S.A., Phillips, E., Mallal, S., De Silva, A.D., Nchinda, G., Nkenfou, C., Collins, M.H., de Silva, A.M., Lim, M.Q., Macary, P.A., Tatullo, F., Solomon, T., Satchidanandam, V., Desai, A., Ravi, V., Coloma, J., Turtle, L., Rivino, L., Kallas, E.G., Peters, B., Harris, E., Sette, A. and Weiskopf, D. (2017) Global assessment of dengue Virus-Specific CD4+ T cell responses in Dengue-Endemic areas. Frontiers in Immunology, 8 .

Trubiano, J.A., Thursky, K.A., Stewardson, A.J., Urbancic, K., Worth, L.J., Jackson, C., Stevenson, W., Sutherland, M., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2017) Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clinical Infectious Diseases, 65 (1). pp. 166-174.

Karnes, J.H., Shaffer, C.M., Cronin, R., Bastarache, L., Gaudieri, S., James, I., Pavlos, R., Steiner, H., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37 (9). pp. 1164-1171.

Grifoni, A., Angelo, M., Sidney, J., Paul, S., Peters, Bjoern, de Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Botten, J., Boyson, J., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and García-Sastre, A. (2017) Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Journal of Virology, 91 (8).

Trubiano, J.A., Adkinson, N.F. and Phillips, E.J. (2017) Penicillin allergy is not necessarily forever. JAMA, 318 (1). p. 82.

Garon, S.L., Pavlos, R.K., White, K.D., Brown, N.J., Stone, C.A. and Phillips, E.J. (2017) Pharmacogenomics of off-target adverse drug reactions. British Journal of Clinical Pharmacology, 83 (9). pp. 1896-1911.

Adler, N.R., Aung, A.K., Ergen, E.N., Trubiano, J., Goh, M.S.Y. and Phillips, E.J. (2017) Recent advances in the understanding of severe cutaneous adverse reactions. British Journal of Dermatology . In Press.

Arlehamn, C.S.L., Copin, R., Leary, S., Mack, S.J., Phillips, E., Mallal, S., Sette, A., Blatner, G., Siefers, H. and Ernst, J.D. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Human Immunology, 78 (4). pp. 325-326.

Peter, J.G., Lehloenya, R., Dlamini, S., Risma, K., White, K.D., Konvinse, K.C. and Phillips, E.J. (2017) Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 547-563.

Pavlos, R., White, K.D., Wanjalla, C., Mallal, S.A. and Phillips, E.J. (2017) Severe delayed drug reactions. Immunology and Allergy Clinics of North America, 37 (4). pp. 785-815.

Pavlos, R., McKinnon, E.J., Ostrov, D.A., Peters, B., Buus, S., Koelle, D., Chopra, A., Schutte, R., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Kaever, T., Myers, P., Speers, E., Malaker, S.A., Shabanowitz, J., Jing, Y., Gaudieri, S., Hunt, D.F., Carrington, M., Haas, D.W., Mallal, S. and Phillips, E.J. (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Scientific Reports, 7 (1).

Sulzer, D., Alcalay, R.N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W.H., Mao, X., Dawson, V.L., Dawson, T.M., Oseroff, C., Pham, J., Sidney, J., Dillon, M.B., Carpenter, C., Weiskopf, D., Phillips, E., Mallal, S., Peters, B., Frazier, A., Lindestam Arlehamn, C.S. and Sette, A. (2017) T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nature, 546 (7660). pp. 656-661.

Derrick, M.I.P., Williams, K.B., Shade, L.M and Phillips, E.J. (2017) A survey of drug allergy training opportunities in the United States. The Journal of Allergy and Clinical Immunology: In Practice, In press .

Elera, J.D., Boteanu, C., Blanco, M.A.J., Gonzalez-Mendiola, R., García, I.C., Alvarez, A., Martinez, J.J.L., Garrido, J.M., Barona, C.T., Chorda, C.P., Salgueiro, R.L., Palacios, M.D., De Rojas, D.H.F., Acar, E.A., Aktas, A., Ermertcan, A.T., Temiz, C., Lin, C-Y, Hui, C-Y.R., Chang, Y-C, Yang, C-H, Chung, W-H, Carolino, F., Silva, D., De Castro, E.D., Cernadas, J.R., Ensina, L.F., Aranda, C., Nunes, I.C., Lacerda, A., Martins, A.M., Goudouris, E., Ribeiro, M., Da Silva Franco, J.F., Queiroz, L., Solé, D., Dalgiç, C.T., Sin, A.Z., Günsen, F.D., Bulut, G., Ardeniz, F.Ö., Gülbahar, O., Gökmen, E.N.M., Kokuludag, A., De Francisco, A.M.M., De Vicente Jiménez, T.M., Mendoza Parra, A.M., Burgos Pimentel, A.M., Luque, A.G., Amaral, L., Leão, L.C., Pinto, N., Belo, J., Marques, J., Carreiro-Martins, P., Leiria-Pinto, P., Chaabane, A., Romdhane, H.B., Fredj, N.B., Chadly, Z., Boughattas, N.A., Aouam, K., Uyttebroek, A.P., Bridts, C.H., Romano, A., Ebo, D.G., Sabato, V., Lopes, A., Cosme, J., Aguiar, R., Lourenço, T., Paes, M-J, Spínola-Santos, A., Pereira-Barbosa, M., Cruz, C.R., Dos Reis, R.P., Tomaz, E., Pires, A.P., Inácio, F., Benito-Garcia, F., Mota, I., Correia, M., Gaspar, Â., Chambel, M., Piedade, S., Morais-Almeida, M., Nakonechna, A., Antipkin, Y., Umanets, T., Pineda, F., Arribas, F., Lapshyn, V., Miranda, P.A., De La Cruz Hoyos, B., Blanco, A.J., Del Pozo, M., Vultaggio, A., Nencini, F., Pratesi, S., Matucci, A., Maggi, E., Cegec, I., Nahal, D.J., Turk, V.E., Aumiler, M.R., Ausperger, K.M., Kraljickovic, I., Simic, I., Yamaguchi, Y., Watanabe, T., Satoh, M., Tanegashima, T., Oda, K., Wada, H., Aihara, M., Lee, J.J., Choi, J.C., Lee, H.Y., Fernandes, R-A.R., Faria, E., Pita, J., Sousa, N., Ribeiro, C., Carrapatoso, I., Bom, A.T., Rodolfo, A., Dias-Castro, E., Voronova, M., Valle, D.K., Coronel, V.P., Chordá, C.P., Madamba, R.C.Y., Ferrer, M., Goikoetxea, M.J., D’Amelio, C., Bernad, A., Vega, O., Gastaminza, G., Bibián, B.L., Salazar, M.L., Vilà-Nadal, G., Roman, A.M.F., Ortega, J.D., Muñoz, M.G., Gancedo, S.Q., Moreno, M.R.C., Hofmeier, K.S., Barzylovych, V., Pola, B., Lluncor, M., Fiandor, A., Bellón, T., Domínguez, J., Quirce, S., Yang, M-S, Kim, S-S, Kim, S-H, Kang, H-R, Park, H-W, Cho, S-H, Min, K-U, Chang, Y-S, Delahaye, C., Flabbee, J., Waton, J., Bauvin, O., Barbaud, A., Fadhel, N.B., Gulin, S.J., Chiriac, A., Cardoso, B.K., Viseu, R., Moreira, A., Cadinha, S., Neves, A.C., Barreira, P., Malheiro, D., Da Silva, J.P., Jurakic-Toncic, R., Ljubojevic, S., Turcic, P., Gilissen, L., Huygens, S., Goossens, A., Andreu, I., Romero, A.M., Cabezas, P.G., Parejo, P.A., Del Carmen Plaza-Serón, M., Doña, I., Blanca-López, N., Flores, C., Galindo, M.L., Molina, A., Perkins, J.R., Cornejo-García, J.A., García-Agúndez, J.A., García-Martín, E., Campo, P., Canto, M.G., Blanca, M., Guéant-Rodríguez, R.M., Jurado-Escobar, R., Barrionuevo, E., Salas, M., Canto, G., Guéant, J-L, Usui, T., Tailor, A., Faulkner, L., Farrell, J., Alfirevic, A., Kevin Park, B., Naisbitt, D.J., Trelles, O., Guerrero, M.A., Upton, A., Ueta, M., Sawai, H., Sotozono, C., Tokunaga, K., Kinoshita, S., Sukasem, C., Satapornpong, P., Tempark, T., Rerknimitr, P., Pairayayutakul, K., Klaewsongkram, J., Koomdee, N., Jantararoungtong, T., Santon, S., Puangpetch, A., Intusoma, U., Tassaneeyakul, W., Theeramoke, V., Ramirez, E., Borobia, A.M., Tong, H., Castañer, J.L., De Abajo, F.J., Galvao, V.R., Pavlos, R., McKinnon, E., Williams, K., Beeghly-Fadiel, A., Phillips, E., Castells, M., Boni, E., Russello, M., Mauro, M., Ue, K.L., Rutkowski, K., Gomis, V.S., Ferre, J.F., Rodriguez, A.E., Reig, V.C., Sanchez, J.F., Breynaert, C., Van Hoeyveld, E., Schrijvers, R., Blanco, A.J., Irigoyen, R.F., Collado, D., Vida, Y., Najera, F., Perez-Inestrosa, E., Mesa-Antunez, P., Mayorga, C., Torres, M.J., Tannert, L.K., Mortz, C.G., Skov, P.S., Bindslev-Jensen, C., Pfützner, W., Dörnbach, H., Visse, J., Rauber, M., Möbs, C., Elzagallaai, A.A., Chow, L., Abuzgaia, A.M., Rieder, M.J., Trubiano, J., Woolnough, E., Cheng, C., Kato, K., Azukizawa, H., Hanafusa, T., Katayama, I., Fujiyama, T., Hashizume, H., Umayahara, T., Ito, T., Tokura, Y., Silar, M., Zidarn, M., Rupnik, H., Korosec, P., Redwood, A.J., Strautins, K., White, K., Chopra, A., Konvinse, K., Leary, S., Mallal, S., Cabañas, R., Fiandor, A.M., Sullivan, A., Whitaker, P., Peckham, D., Haw, W.Y., Polak, M.E., Mcguire, C., Ardern-Jones, M.R., Aoyama, Y., Shiohara, T., Correia, S., Gelincik, A., Demir, S., Sen, F., Bozbey, H.U., Olgac, M., Unal, D., Coskun, R., Colakoglu, B., Buyuozturk, S., Çatin-Aktas, E., Deniz, G., Laguna, J.J., Dionicio, J., Fernandez, T., Olazabal, I., Ruiz, M.D., Torres, M.J., Lafuente, A., Núñez, J., Fernández, T.D., Palomares, F., Fernández, R., Sanchez, M.I., Fernandez, T., Ruiz, A., Ariza, A., Alonso, A.B., Garófalo, C.D., Matute, O.V., Puga, M.F., Lapresa, M.J.G., Lasarte, G.G., Thinnes, A., Merk, H.F., Baron, J.M., Leverkus, M., Balakirski, G., Gibson, A., Ogese, M., Al-Attar, Z., Yaseen, F., Meng, X., Jenkins, R., Farrel, J., Alhilali, K., Xue, Y., Illing, P., Mifsud, N., Fettke, H., Lai, J., Ho, R., Kwan, P., Purcell, A., Ogese, M.O., Betts, C., Thomson, P., Alhaidari, M., Berry, N., O’Neill, P.M., Alzahrani, A., Azoury, M.E., Fili, L., Bechara, R., Scornet, N., Nhim, C., Weaver, R., Claude, N., Joseph, D., Maillere, B., Parronchi, P., Pallardy, M., Villani, A.P., Rozières, A., Bensaïd, B., Tardieu, M., Albert, F., Mutez, V., Baysal, T., Maryanski, J., Nicolas, J-F, Kanagawa, O., Vocanson, M., Hung, S-L, Harrison, C.J., Jenkins, R.E., French, N.S., Montañez, M.I., Fernandez, T.D., Martin-Serrano, A., Torres, M.J., Molina, N., Wood, S., Pirmohamed, M., Montañez, M.I., Martín-Serrano, Á., Pérez-Inestrosa, E., Pérez-Sala, D., Guzmán, A.E., Ko, T-M, Chen, Y-T, Wu, J-Y, Sánchez-Gómez, F.J., González-Morena, J.M., Torres, M.J., Arreola, A.M., Corona, J.A.B., Flores, S.M., Cherit, J.D., Figueroa, N.V.D., Flores, J.L.C., Perkins, J., Pérez-Alzate, D., Bogas, G., Torres, M.J., Marti, L.M.T., De La Losa, F.P., Poves, F.A., Lopez, J.T. and Santiago, T.L. (2016) 7th Drug hypersensitivity meeting: part two. Clinical and Translational Allergy, 6 (S3).

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2016) Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism. Journal of Allergy and Clinical Immunology, 139 (5). pp. 1710-1713.

Trubiano, J.A., Beekmann, S.E., Polgren, P.M., Worth, L.J., Grayson, M.L. and Phillips, E.J. (2016) Antibiotic allergy De-Labeling: Teaching an old dog new tricks. Journal of Allergy and Clinical Immunology, 137 (2). AB398.

Galvão, V.R., Phillips, E., Giavina-Bianchi, P. and Castells, M.C. (2016) Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 816-818.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Characterizing immune responses in severe T-cell mediated adverse drug reaction. The Journal of Immunology, 196 (Supp. 1).

Phillips, E.J. (2016) Classifying ADRs - Does dose matter? British Journal of Clinical Pharmacology, 81 (1). pp. 10-12.

Trubiano, J.A., Redwood, A., Strautins, K., Pavlos, R., Woolnough, E., Chang, C.C. and Phillips, E. (2016) Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 823-826.

Jing, L., Laing, K.J., Dong, L., Russell, R.M., Barlow, R.S., Haas, J.G., Ramchandani, M.S., Johnston, C., Buus, S., Redwood, A.J., White, K.D., Mallal, S.A., Phillips, E.J., Posavad, C.M., Wald, A. and Koelle, D.M. (2016) Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. The Journal of Immunology, 196 (5). pp. 2205-2218.

Weiskopf, D., Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., De Silva, A.D., Phillips, E., Mallal, S., Premawansa, S., Premawansa, G., Wijewickrama, A., Peters, B. and Sette, A. (2016) HLA-DRB1 alleles are associated with different magnitudes of dengue Virus–Specific CD4+T-Cell responses. Journal of Infectious Diseases, 214 (7). pp. 1117-1124.

Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., Peters, B., De Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and Frueh, K. (2016) Human CD4 + T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity. Journal of Virology, 91 (5).

Mosley, J.D., Witte, J.S., Larkin, E.K., Bastarache, L., Shaffer, C.M., Karnes, J.H., Stein, C.M., Phillips, E., Hebbring, S.J., Brilliant, M.H., Mayer, J., Ye, Z., Roden, D.M. and Denny, J.C. (2016) Identifying genetically driven clinical phenotypes using linear mixed models. Nature Communications, 7 .

Trubiano, J.A., Beekmann, S.E., Worth, L.J., Polgreen, P.M., Thursky, K.A., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2016) Improving antimicrobial stewardship by antibiotic allergy delabeling: Evaluation of knowledge, attitude, and practices throughout the emerging infections network. Open Forum Infectious Diseases, 3 (3).

Metushi, I., Uetrecht, J. and Phillips, E. (2016) Mechanism of isoniazid-induced hepatotoxicity: Then and now. British Journal of Clinical Pharmacology, 81 (6). pp. 1030-1036.

Murray, T.S., Rice, T.W., Wheeler, A.P., Phillips, E.J., Dworski, R.T. and Stollings, J.L. (2016) Medication desensitization: Characterization of outcomes and risk factors for reactions. Annals of Pharmacotherapy, 50 (3). pp. 203-208.

Konvinse, K.C., Phillips, E.J., White, K.D. and Trubiano, J.A. (2016) Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Current Opinion in Infectious Diseases, 29 (6). pp. 561-576.

Trubiano, J.A., Worth, L.J., Urbancic, K., Brown, T.M., Paterson, D.L., Lucas, M. and Phillips, E. (2016) Return to Sender: The need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal, 46 (11). pp. 1311-1317.

Pham, J., Oseroff, C., Hinz, D., Sidney, J., Paul, S., Greenbaum, J., Vita, R., Phillips, E., Mallal, S., Peters, B. and Sette, A. (2016) Sequence conservation predicts T cell reactivity against ragweed allergens. Clinical & Experimental Allergy, 46 (9). pp. 1194-1205.

Gerace, K., Wang, L. and Phillips, E.J. (2016) The negative impact of persistent penicillin allergy labeling. Journal of Allergy and Clinical Immunology, 137 (2). AB397.

Murray, T., Rice, T., Wheeler, A., Phillips, E., Dworski, R. and Stollings, J. (2015) 626: Drug desensitization outcomes and risk factors for skin reactions in adults. Critical Care Medicine, 43 . p. 158.

Shoukry, N.H., Lucas, A., Lucas, M., Strhyn, A., Keane, N.M., McKinnon, E., Pavlos, R., Moran, E.M., Meyer-Pannwitt, V., Gaudieri, S., D’Orsogna, L., Kalams, S., Ostrov, D.A., Buus, S., Peters, B., Mallal, S. and Phillips, E. (2015) Abacavir-Reactive memory T Cells are present in drug naïve individuals. PLoS ONE, 10 (2). e0117160.

Metushi, I.G., Wriston, A., Banerjee, P., Gohlke, B.O., English, A.M., Lucas, A., Moore, C., Sidney, J., Buus, S., Ostrov, D.A., Mallal, S., Phillips, E., Shabanowitz, J., Hunt, D.F., Preissner, R. and Peters, B. (2015) Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. PloS one, 10 (5). e0124878.

Martin, J.H., Phillips, E., Thomas, D. and Somogyi, A.A. (2015) Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes. British Journal of Clinical Pharmacology, 80 (5). pp. 929-931.

Saito, Y., Stamp, L.K., Caudle, K.E., Hershfield, M.S., McDonagh, E.M., Callaghan, J.T., Tassaneeyakul, W., Mushiroda, T., Kamatani, N., Goldspiel, B.R., Phillips, E.J., Klein, T.E. and Lee, M.T.M. (2015) Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics, 99 (1). pp. 36-37.

White, K.D., Chung, W-H, Hung, S-L, Mallal, S. and Phillips, E.J. (2015) Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response. Journal of Allergy and Clinical Immunology, 136 (2). pp. 219-234.

Sterling, T.R., Moro, R.N., Borisov, A.S., Phillips, E., Shepherd, G., Adkinson, N.F., Weis, S., Ho, C. and Villarino, M.E. (2015) Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study. Clinical Infectious Diseases, 61 (4). pp. 527-535.

Bourke, J., Pavlos, R., James, I. and Phillips, E. (2015) Improving the effectiveness of penicillin allergy De-labeling. The Journal of Allergy and Clinical Immunology: In Practice, 3 (3). pp. 365-374.

Gerace, K. and Phillips, E. (2015) Penicillin allergy label persists despite negative testing. Journal of Allergy and Clinical Immunology, 135 (2). AB113.

Wheatley, L.M., Plaut, M., Schwaninger, J.M., Banerji, A., Castells, M., Finkelman, F.D., Gleich, G.J., Guttman-Yassky, E., Mallal, S.A.K., Naisbitt, D.J., Ostrov, D.A., Phillips, E.J., Pichler, W.J., Platts-Mills, T.A.E., Roujeau, J-C, Schwartz, L.B. and Trepanier, L.A. (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Journal of Allergy and Clinical Immunology, 136 (2). 262-271.e2.

Pavlos, R., Mallal, S., Ostrov, D., Buus, S., Metushi, I., Peters, B. and Phillips, E. (2015) T Cell–Mediated hypersensitivity reactions to drugs. Annual Review of Medicine, 66 (1). pp. 439-454.

Gerace, K.S., Karlin, E., McKinnon, E. and Phillips, E. (2015) Varying penicillin allergy testing practices in the United States: A time for consensus. The Journal of Allergy and Clinical Immunology: In Practice, 3 (5). pp. 791-793.

Tseng, A., Seet, J. and Phillips, E.J. (2015) The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future. British Journal of Clinical Pharmacology, 79 (2). pp. 182-194.

Hemler, J.A., Phillips, E.J., Mallal, S.A. and Kendall, P.L. (2015) The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Annals of Allergy, Asthma & Immunology, 115 (6). pp. 471-476.

Milpied-Homsi, B., Moran, E.M. and Phillips, E.J. (2014) Antiviral Drug Allergy. Immunology and Allergy Clinics of North America, 34 (3). pp. 645-662.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E.J. (2014) Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. British Journal of Clinical Pharmacology, 78 (7). pp. 14-23.

Pavlos, R., Mallal, S., Ostrov, D., Pompeu, Y. and Phillips, E. (2014) Fever, rash, and systemic symptoms: Understanding the role of virus and HLA in severe cutaneous drug allergy. The Journal of Allergy and Clinical Immunology: In Practice, 2 (1). pp. 21-33.

Karlin, E. and Phillips, E. (2014) Genotyping for severe drug hypersensitivity. Current Allergy and Asthma Reports, 14 (3).

Keane, N.M., Pavlos, R.K., McKinnon, E., Lucas, A., Rive, C., Blyth, C.C., Dunn, D., Lucas, M., Mallal, S. and Phillips, E. (2014) HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity. AIDS, 28 (13). pp. 1891-1901.

Rive, C., Pavlos, R., Ostrov, D., Plasencia, P., Hung, S-L, Chung, W.H., Peters, B., Buus, S., Mallal, S. and Phillips, E. (2014) HLA class I-drug-T-cell receptor interactions in SJS/TEN. Clinical and Translational Allergy, 4 (Suppl. 3). P2.

Stone, S.F., Phillips, E.J., Wiese, M.D., Heddle, R.J. and Brown, S.G.A (2014) Immediate-type hypersensitivity drug reactions. British Journal of Clinical Pharmacology, 78 (1). pp. 1-13.

Aung, A.K., Haas, D.W., Hulgan, T. and Phillips, E.J. (2014) Pharmacogenomics of antimicrobial agents. Pharmacogenomics, 15 (15). pp. 1903-1930.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E. (2014) Response to letter regarding article ‘Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis’. British Journal of Clinical Pharmacology, 78 (4). pp. 931-932.

Trubiano, J. and Phillips, E. (2013) Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling'. Current Opinion in Infectious Diseases, 26 (6). pp. 526-537.

Phillips, E. (2013) Antiretroviral therapy. Internal Medicine Journal, 43 . pp. 11-12.

Phillips, E., Bartlett, J.A., Sanne, I., Lederman, M.M., Hinkle, J., Rousseau, F., Dunn, D., Pavlos, R., James, I., Mallal, S.A. and Haas, D.W. (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62 (2). e55-e57.

Hertz, T., Oshansky, C., Roddam, P., DeVincenzo, J., Caniza, M., Jojic, N., Mallal, S., Phillips, E., James, I., Thomas, P., Halloran, M. and Corey, L. (2013) HLA targeting efficiency correlates with human T cell response magnitude and with mortality from influenza A infection. The Journal of Immunology, 190 (Supp. 1). 49.21.

Hertz, T., Oshansky, C.M., Roddam, P.L., DeVincenzo, J.P., Caniza, M.A., Jojic, N., Mallal, S., Phillips, E., James, I., Halloran, M.E., Thomas, P.G. and Corey, L. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proceedings of the National Academy of Sciences, 110 (33). pp. 13492-13497.

Phillips, E.J. and Mallal, S.A. (2013) HLA-B*5701 and flucloxacillin associated drug-induced liver disease. AIDS, 27 (3). pp. 491-492.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing delayed drug hypersensitivity. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing for drug hypersensitivity syndromes. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. Journal of the International AIDS Society, 15 (6(Suppl 4)). p. 18119.

Hammond, E., McKinnon, E., Glendenning, P., Williams, R., Mallal, S. and Phillips, E. (2012) Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clinical Endocrinology, 76 (2). pp. 201-206.

Ostrov, D.A., Grant, B.J., Pompeu, Y.A., Sidney, J., Harndahl, M., Southwood, S., Oseroff, C., Lu, S., Jakoncic, J., de Oliveira, C.A.F., Yang, L., Mei, H., Shi, L., Shabanowitz, J., English, A.M., Wriston, A., Lucas, A., Phillips, E., Mallal, S., Grey, H.M., Sette, A., Hunt, D.F., Buus, S. and Peters, B. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences, 109 (25). pp. 9959-9964.

Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11). pp. 1285-1306.

Pavlos, R. and Phillips, E.J. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine, 5 (1). pp. 1-17.

Lee, M.H., Stocker, S.L., Anderson, J., Phillips, E.J., Nolan, D., Williams, K.M., Graham, G.G., Sullivan, J.R. and Day, R.O. (2012) Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status? Internal Medicine Journal, 42 (4). pp. 411-416.

McGettigan, B.D., Hew, M., Phillips, E. and McLean-Tooke, A. (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ: Case Reports, 2012 (21 Sept 2012).

Pompeu, Y.A., Stewart, J.D., Mallal, S., Phillips, E., Peters, B. and Ostrov, D.A. (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunological Reviews, 250 (1). pp. 158-166.

Phillips, E.J., Chung, W-H, Mockenhaupt, M., Roujeau, J-C and Mallal, S. (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. Journal of Allergy and Clinical Immunology, 127 (3). S60-S66.

Phillips, E.J. and Mallal, S.A. (2011) HLA-B*1502 Screening and toxic effects of carbamazepine. New England Journal of Medicine, 365 (7). pp. 672-673.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E.J., Huang, J.C., Riadi, G., Mallal, S. and Jojic, N. (2011) Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins. Journal of Virology, 85 (3). pp. 1310-1321.

Haas, D.W., Kuritzkes, D.R., Ritchie, M.D., Amur, S., Gage, B.F., Maartens, G., Masys, D., Fellay, J., Phillips, E., Ribaudo, H.J., Freedberg, K.A., Petropoulos, C., Manolio, T.A., Gulick, R.M., Haubrich, R., Kim, P., Dehlinger, M., Abebe, R. and Telenti, A. (2011) Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials, 12 (5). pp. 277-285.

Pirmohamed, M., Friedmann, P.S., Molokhia, M., Loke, Y.K., Smith, C., Phillips, E., La Grenade, L., Carleton, B., Papaluca-Amati, M., Demoly, P. and Shear, N.H. (2011) Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury. Clinical Pharmacology & Therapeutics, 89 (6). pp. 896-901.

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Hammond, E., Lucas, A., Lucas, M., Phillips, E. and Gaudieri, S. (2010) Vaniprevir: HCV NS3/4A protease inhibitor treatment of hepatitis C. Drugs of the Future, 35 (10). pp. 803-813.

Phillips, E.J. and Mallal, S. (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.

Phillips, E.J. and Mallal, S. (2009) Personalizing antiretroviral therapy: is it a reality? Personalized Medicine, 6 (4). pp. 393-408.

Kesselring, A.M., Wit, F.W., Sabin, C.A., Lundgren, J.D., Gill, M.J., Gatell, J.M., Rauch, A., Montaner, J.S., de Wolf, F., Reiss, P., Mocroft, A. and Phillips, E. (2009) Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS, 23 (13). pp. 1689-1699.

Phillips, E.J. and Mallal, S. (2009) Successful translation of pharmacogenetics into the clinic: The abacavir example. Molecular Diagnosis and Therapy, 13 (1). pp. 1-9.

Chaubey, S.K., Sinha, A.K., Phillips, E., Russell, D.B. and Falhammar, H. (2009) Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sexual Health, 6 (3). pp. 254-257.

Mocroft, A., Sterne, J.A., Egger, M., May, M., Grabar, S., Furrer, H., Sabin, C., Fatkenheuer, G., Justice, A., Reiss, P., D'Arminio Monforte, A., Gill, J., Hogg, R., Bonnet, F., Kitahata, M., Staszewski, S., Casabona, J., Harris, R., Saaq, M. and Phillips, E. (2009) Variable impact on mortality of AIDS‐Defining events diagnosed during combination antiretroviral therapy: Not All AIDS‐defining conditions are created equal. Clinical Infectious Diseases, 48 (8). pp. 1138-1151.

Phillips, E., Nolan, D. and Mallal, S. (2008) The Authors reply - Response to Vandekerckhove et al & Abel et al. New England Journal of Medicine, 358 (23). pp. 2515-2516.

Almeida, C.M., Martin, A.M., Nolan, D., Lucas, A., Cameron, P.U., James, I., Phillips, E. and Mallal, S. (2008) Cytokine profiling in abacavir hypersensitivity patients. Antiviral Therapy, 13 (2). pp. 281-288.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J.F., Hay, P., Nolan, D., Hughes, S., Hughes, A., Ryan, S., Fitch, N., Thorborn, D. and Benbow, A. (2008) HLA-B*5701 screening for hypersensitivity to Abacavir. The New England Journal of Medicine, 358 (6). pp. 568-579.

Saag, M., Balu, R., Phillips, E.J., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., Hughes, A., Sutherland‐Phillips, D., Mallal, S. and Shaefer, M. (2008) High sensitivity of human leukocyte antigen–B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clinical Infectious Diseases, 46 (7). pp. 1111-1118.

Phillips, E., Hayden, A., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2008) Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply. AIDS, 22 (4). pp. 548-549.

Phillips, E.J. and Mallal, S.A. (2008) Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Current Opinion in Infectious Diseases, 21 (1). pp. 16-24.

Rauch, A., Nolan, D., Thurnheer, C., Fux, C.A., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral Therapy, 13 (8). pp. 1019-1028.

Shear, N.H., Milpied, B., Bruynzeel, D.P. and Phillips, E.J. (2008) A review of drug patch testing and implications for HIV clinicians. AIDS, 22 (9). pp. 999-1007.

Raboud, J., Lesosky, M., Sterling, S., Phillips, E.J., Walmsley, S. and Bayoumi, A. (2007) An Estimate of the proportion of symptoms reported in Self-administered questionnaires that are captured as adverse drug events in an observational database. HIV Clinical Trials, 8 (5). pp. 311-319.

Phillips, E.J. and Mallal, S. (2007) Drug hypersensitivity in HIV. Current Opinion in Allergy and Clinical Immunology, 7 (4). pp. 324-330.

Martin, A., Almeida, C.M., Cameron, P.U., Purcell, Anthony W, Nolan, D., James, I., McCluskey, J., Phillips, E.J., Landay, Alan and Mallal, S. (2007) Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS, 21 (10). pp. 1233-1244.

Phillips, E., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2007) Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. AIDS, 21 (12). pp. 1561-1568.

Hammond, E., Almeida, C.M., Mamotte, C., Nolan, D., Phillips, E.J., Schollaardt, T.A., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D., Chew, C.B., Neifer, S., Lalonde, R., Roger, M., Jeanneau, A. and Mallal, S. (2007) External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Antiviral Therapy, 12 (7). pp. 1027-1032.

Mallal, S. and Phillips, E. (2007) Introduction of pharmacogenetic screening to HIV clinical practice: Potential benefits and challenges. European Infectious Diseases (2). pp. 13-18.

Tansey, C.M., Louie, M., Loeb, M., Gold, W.L., Muller, M.P., De Jager, J., Cameron, J.I., Tomlinson, G., Mazulli, T., Walmsley, S.L., Rachlis, A.R., Mederski, B.D., Silverman, M., Shainhouse, Z., Ephtimios, I.E., Avendano, M., Downey, J., Styra, R., Yamamura, D., Gerson, M., Stanbrook, M.B., Marras, T.K., Phillips, E.J., Zamel, N., Richardson, S.E., Slutsky, A.S. and Herridge, M.S. (2007) One-Year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Archives of Internal Medicine, 167 (12). pp. 1312-1320.

Simor, A.E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H.R. and Kiss, A. (2007) Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant staphylococcus aureus colonization. Clinical Infectious Diseases, 44 (2). pp. 178-185.

Chui, C.K.S., Brumme, Z.L., Brumme, C.J., Yip, B., Phillips, E.J., Montaner, J.S.G. and Harrigan, P.R. (2007) A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Clinical Infectious Diseases, 44 (11). pp. 1503-1508.

Nolan, D., Phillips, E. and Mallal, S. (2006) Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance. Clinical Infectious Diseases, 42 (3). pp. 408-410.

Phillips, E.J. (2006) Genetic screening to prevent abacavir hypersensitivity reaction: Are we there yet? Clinical Infectious Diseases, 43 (1). pp. 103-105.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E.J., Knowles, S. and Rachlis, A. (2006) Glucose homeostasis abnormalities and gatifloxacin. Clinical Infectious Diseases, 42 (6). p. 895.

Tang, P., Walsh, S., Murray, C., Alterman, C., Varia, M., Broukhanski, G., Chedore, P., DeKoven, J., Assaad, D., Gold, W.L., Ghazarian, D., Finkelstein, M., Pritchard, M., Yaffe, B., Jamieson, F., Henry, B. and Phillips, E. (2006) Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections. Journal of Cutaneous Medicine and Surgery, 10 (4). pp. 166-169.

Phillips, E.J. (2006) The pharmacogenetics of antiretroviral therapy. Current Opinion in HIV and AIDS, 1 (3). pp. 249-256.

Martin, A.M., Krueger, R., Almeida, C.A., Nolan, D., Phillips, E. and Mallal, S. (2006) A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenetics and Genomics, 16 (5). pp. 353-357.

Mishra, S. and Phillips, E. (2005) Antifungals: What's new? The Canadian Journal of Diagnosis, 22 (1). pp. 81-83.

Notman, M.J., Phillips, E.J., Knowles, S.R., Weber, E.A. and Shear, N.H. (2005) Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis, 53 (6). pp. 335-338.

Phillips, E.J., Wong, G., Kaul, R., Shahabi, K., Nolan, D., Knowles, S.R., Martin, A.M., Mallal, S. and Shear, N.H. (2005) Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS, 19 (9). pp. 979-981.

van Heeswijk, R.P.G., Cooper, C.L., Foster, B.C., Chauhan, B.M., Shirazi, F., Seguin, I., Phillips, E.J. and Mills, E. (2005) Effect of High-Dose vitamin C on hepatic cytochrome P450 3A4 activity. Pharmacotherapy, 25 (12). pp. 1725-1728.

Knowles, S.R., Wong, G.A., Rahim, S.A., Binkley, K., Phillips, E.J. and Shear, N.H. (2005) Hydrochlorothiazide-Induced noncardiogenic pulmonary edema: An underrecognized yet serious adverse drug reaction. Pharmacotherapy, 25 (9). pp. 1258-1265.

Mills, E., Foster, B.C., van Heeswijk, R.P.G., Phillips, E., Wilson, K., Leonard, B., Kosuge, K. and Kanfer, I. (2005) Impact of African herbal medicines on antiretroviral metabolism. AIDS, 19 (1). pp. 95-97.

Mills, E., Wilson, K., Clarke, M., Foster, B., Walker, S., Rachlis, B., DeGroot, N., Montori, V.M., Gold, W., Phillips, E., Myers, S. and Gallicano, K. (2005) Milk thistle and indinavir: A randomized controlled pharmacokinetics study and meta-analysis. European Journal of Clinical Pharmacology, 61 (1). pp. 1-7.

Mills, E., Montori, V., Perri, D., Phillips, E. and Koren, G. (2005) Natural health product-HIV drug interactions: a systematic review. International Journal of STD & AIDS, 16 (3). pp. 181-186.

Martin, A.M., Nolan, D., James, I., Cameron, P., Keller, J., Moore, C., Phillips, E., Christiansen, F.T. and Mallal, S. (2005) Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. AIDS, 19 (1). pp. 97-99.

Antoniou, T., Tseng, A.L., van Heeswijk, R.P.G., Walker, S.E., Giquere, P. and Phillips, E.J. (2005) Steady-State pharmacokinetics and tolerability of Indinavir-Lopinavir/R Combination therapy in Antiretroviral-experienced patients. Therapeutic Drug Monitoring, 27 (6). pp. 779-781.

Phillips, E.J. and Knowles, S.R. (2005) Sulfonamide cross-reactivity: Fact or fiction? Annals of Pharmacotherapy, 39 (7). pp. 1372-1373.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E., Knowles, S. and Rachlis, A. (2004) Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia associated with marketed systemic fluoroquinolones made to the Canadian adverse drug reaction monitoring program. Canadian Journal of Hospital Pharmacy, 57 (1). pp. 12-17.

Tang, P., Louie, M., Richardson, S.E., Smieja, M., Simor, A.E., Jamieson, F., Fearon, M., Poutanen, S.M., Mazzulli, T., Tellier, R., Mahony, J., Loeb, M., Petrich, A., Chernesky, M., McGeer, A., Low, D.E., Phillips, E., Jones, S., Bastien, N., Li, Y., Dick, D., Grolla, A., Fernando, L., Booth, T.F., Henry, B., Rachlis, A.R., Matukas, L.M., Rose, D.B., Lovinsky, R., Walmsley, S., Gold, W.L., Krajden, S. and Ontario Laboratory Working Group, The (2004) Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: The Toronto experience. Canadian Medical Association Journal, 170 (1). pp. 47-54.

Martin, A.M., Nolan, D., Gaudieri, S., Phillips, E. and Mallal, S. (2004) Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics, 5 (6). pp. 643-655.

Martin, A.M., Nolan, D., Gaudieri, S., Almeida, C., James, I., Phillips, E. and Mallal, S. (2004) Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proceedings of the National Academy of Sciences, 101 (12). pp. 4180-4185.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E., Knowles, S. and Rachlis, A. (2004) Quinolone hyperglycemia and hypoglycemia. Canadian Journal of Hospital Pharmacy, 57 (3). pp. 183-184.

Knowles, S.R., Phillips, E.J., Wong, G. and Shear, N.H. (2004) Serious dermatologic reaction associated with valdecoxib: Report of two cases. Journal of the American Academy of Dermatology, 51 (6). pp. 1028-1029.

Heeswijk, R., Khaliq, Y., Gallicano, K., Bourbeau, M., Seguin, I., Phillips, E. and Cameron, D. (2004) The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clinical Pharmacology & Therapeutics, 76 (6). pp. 588-597.

Thistle, P., Gottesman, M., Pilon, R., Glazier, R.H., Arbess, G., Phillips, E., Wald, R.L., Chitsike, I., Simor, A., Chipato, T. and Silverman, M. (2004) A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. The Central African Journal of Medicine, 50 (9-10). pp. 79-84.

Sullivan, J.R., Rachlis, A. and Phillips, E. (2003) 'Buffalo-hump' dermatitis: A hat trick of antiretroviral side-effects. Contact Dermatitis, 48 (3). pp. 169-170.

Park-Wyllie, L.Y. and Phillips, E.J. (2003) Challenges of adherence management in human immunodeficiency virus pharmacotherapy. Canadian Journal of Clinical Pharmacology, 10 (4). pp. 189-195.

Valois, M., Phillips, E.J., Shear, N.H. and Knowles, Sandra R. (2003) Clindamycin-associated acute generalized exanthematous pustulosis. Contact Dermatitis, 48 (3). p. 169.

Loutfy, M., Raboud, J., Thompson, C., Tseng, A., Abdurrahman, Z., Kovacs, C., Rachlis, A., Phillips, E., Rubin, G., Gough, K. and Walmsley, S. (2003) Clinical impact of double protease inhibitor boosting with Lopinavir/Ritonavir and Amprenavir as part of salvage antiretroviral therapy. HIV Clinical Trials, 4 (5). pp. 301-310.

Knowles, S.R., Phillips, E.J., Dresser, L. and Matukas, L. (2003) Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clinical Infectious Diseases, 37 (8). pp. 1139-1142.

Phillips, E.J., Knowles, S.R. and Shear, N. (2003) Cutaneous manifestations of antiviral therapy. Journal of the American Academy of Dermatology, 48 (6). pp. 985-986.

Phillips, E.J., Rachlis, A.R. and Ito, S. (2003) Digoxin toxicity and ritonavir: A drug interaction mediated through p-glycoprotein? AIDS, 17 (10). pp. 1577-1578.

Koren, G., King, S., Knowles, S. and Phillips, E. (2003) Ribavirin in the treatment of SARS: A new trick for an old drug? Canadian Medical Association Journal, 168 (10). pp. 1289-1292.

Phillips, E.J., Knowles, S.R. and Shear, N.H. (2003) Serum sickness-like reaction associated with clopidogrel. British Journal of Clinical Pharmacology, 56 (5). p. 583.

Phillips, E.J., Kuriakose, B. and Knowles, S.R. (2002) Efavirenz-induced skin eruption and successful desensitization. The Annals of Pharmacotherapy, 36 (3). pp. 430-432.

Neuman, M.G., Malkiewicz, I., Phillips, E.J., Rachlis, A.R., Ong, D., Yeung, E. and Shear, N.H. (2002) Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency Virus-infected individuals. Therapeutic Drug Monitoring, 24 (6). pp. 728-736.

Phillips, E., Sullivan, J.R., Knowles, S.R. and Shear, N.H. (2002) Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS, 16 (16). pp. 2223-2225.

Phillips, E., Knowles, S.R., Weber, E.A. and Blackburn, D. (2001) Cephalexin tolerated despite delayed aminopenicillin reactions. Allergy, 56 (8). p. 790.

Boogaerts, M., Winston, D.J., Bow, E.J., Garber, G., Reboli, A.C., Schwarer, A.P., Novitzky, N., Boehme, A., Chwetzoff, E., de Beule, K. and Phillips, E. (2001) Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving Broad-spectrum antibacterial therapy: A randomized, controlled trial. Annals of Internal Medicine, 135 (6). pp. 412-422.

Phillips, E., Louie, M., Knowles, S.R., Simor, A.E. and Oh, P. (2000) Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic. American Journal of Health-System Pharmacy, 57 (4). pp. 339-345.

Phillips, E. and Simor, A. (1998) Bacterial meningitis in adults and children. Postgraduate Medicine, 103 (3). pp. 102-117.

Phillips, E., Liu, B.A. and Knowles, S.R. (1998) Rapid onset of risperidone-induced hepatotoxicity. Annals of Pharmacotherapy, 32 (7). p. 843.

Phillips, E., Knowles, S., Weber, E. and Shear, N. (1998) Skin reactions associated with bisphosphonates: A report of 3 cases and an approach to management. Journal of Allergy and Clinical Immunology, 102 (4). pp. 697-698.

Phillips, E. (1998) Toxoplasmosis. Canadian Family Physician, 44 (Sept. 1998). pp. 1823-1827.

Einarson, A., Phillips, E., Mawji, F., D'Alimonte, D., Schick, B., Addis, A., Mastroiacova, P., Mazzone, T., Matsui, D. and Koren, G. (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. American Journal of Perinatology, 15 (9). pp. 523-525.

Phillips, E. (1997) The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-Infected subjects. Brain, Behavior, and Immunity, 11 (3). pp. 217-227.

Phillips, E.J., Keystone, J.S. and Kain, K.C. (1996) Failure of combined chloroquine and High-Dose primaquine therapy for plasmodium vivax malaria acquired in Guyana, South America. Clinical Infectious Diseases, 23 (5). pp. 1171-1173.

Soskolne, C.L., Heyland, D. and Phillips, E. (1986) Human T-lymphotropic virus: Exposure and prognosis. Canadian Medical Association Journal, 134 (6). pp. 575-577.

Conference Paper

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

Phillips, E., Nolan, D., Thornborn, D., Schaefer, M., Laird, R., Rauch, A., Montaner, J., Hughes, A., James, I. and Mallal, S. Genetic factors predicting Abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals: combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, Massachusetts, USA

Conference Item

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Allergic Mechanisms: Characterizing immune responses in severe T-cell mediated adverse drug reaction. In: American Association of Immunologists Conference, (AAI) 2016, 13 - 17 May 2016, Seattle, USA.

White, K.D., Konvinse, K., Pilkington, M., Barnett, L., Gangula, R., Redwood, A., Pavlos, R., Chopra, A., Mallal, S. and Phillips, E. (2016) Characterization of TCR repertoire diversity and tissue distribution of drug-specific T cells in DRESS. In: 16th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS) 2016, 22 - 26 June 2016, Boston, MA.

Redwood, A.J., Trubiano, J.A., Pavlos, R., Woolnough, E., Strautins, K., Chang, C. and Phillips, E. (2016) Enzyme linked Immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Phillips, E. (2016) HLA and translation into Drug Hypersensitivity practice. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Phillips, E. (2016) Improving phenotypic precision & using pharmacogenomics to understand mechanisms of drug hypersensitivity reactions. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Phillips, E. (2016) Improving the prediction of drug action. In: ASCPT, 8 - 12 March 2016, San Diego, USA.

White, K., Redwood, A., Jing, L., Konvinse, K., Pavlos, R., Koelle, D., Mallal, S. and Phillips, E. (2016) Isolation of activated CD8+ T cells following drug stimulation: A first step toward evaluating the heterologous immunity model for pure T-cell mediated adverse drug reactions. In: American Society for Clinical Investigation (ASCI) Meeting, 15 - 17 April 2016, Chicago, IL.

Phillips, E. (2016) Pharmacogenomics in drug hypersensitivity practice. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Redwood, A., White, K., Strautins, K., Chopra, A., Konvinse, K., Leary, S., Pavlos, R., Mallal, S. and Phillips, E. (2016) Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Pavlos, R., McKinnon, E., Ostrov, D., Peters, B., Buus, S., Koelle, D., Chopra, A., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Yuan, J., Gaudieri, S., Carrington, M., Haas, D., Mallal, S. and Phillips, E. (2016) Specific binding characteristics Of HLA Alleles associated with nevirapine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Phillips, E. (2016) TPS 10 Anaphylaxis in drug hypersensitivity and LB TPS 9 Drug Allergy II. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Phillips, E. (2016) Translational drug safety: Predicting and preventing severe immunologically-mediated drug reactions. In: Drug Safety Gordon Research Conference 2016, 26 June - 1 July 2016, Stonehill College, Easton, Massachussetts.

Phillips, E. (2016) Utility of HLA in Pharmacogenomic testing. In: IGNITE Meeting, 27 January 2016, Nashville, Tennessee.

Pavlos, R., Strautins, K., James, I., Mallal, S., Redwood, A.J. and Phillips, E. (2016) Variation in EraP Influencees Risk for HLA-B*57:01 positive abacavir hypersensitivity. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI) 2016, 22 - 25 February 2016, Boston, MA.

Phillips, E. (2015) Current science and translational opportunities in the prediction and prevention of immunologically-mediated adverse drug reactions. In: 54th Annual Meeting Society of Toxicology (SOT) and ToxExpo, 22 - 26 March 2015, San Diego, CA.

Phillips, E. (2015) Defining and prioritizing unmet research needs for a deadly disease. In: Research Directions in Genetically-mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), 3 - 4 March 2015, Rockville, Maryland.

Redwood, A., Jing, L., Tran, T., White, K., Mallal, S., Koelle, D. and Phillips, E. (2015) In search of a virotope: Identification of herpesvirus specific CD8T cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Phillips, E. (2015) Personalized approaches to severe immunologically mediated drug reactions: Abacavir hypersensitivity and HLA-B*57:01 as a roadmap for science and translation. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Personalized approaches to severe immunologically-mediated drug reactions. In: Future Directions in Personalized Medicine, 5 February 2015, Vanderbilt University, Nashville, Tennessee.

Mallal, S. and Phillips, E. (2015) Personalizing immunology: The immunopathogenesis of severe T-cell mediated drug hypersensitivity. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Pharmacogenomics of severe adverse reactions to antituberculous medications. In: NIAID Host Response to TB-HIV Infections, 13 - 14 January 2015, Rockville, Maryland.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Plascensia, P.C., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E.J. (2015) Specific binding characteristics of HLA alleles associate with nevirapine hypersensitivity. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Phillips, E. (2015) Translational opportunities in the prediction and prevention of drug hypersensitivity. In: Telethon Kids Research Retreat, 29 - 30 October 2015, Rottnest Island, Perth.

Phillips, E. (2015) Understanding and preventing HLA-associated drug reactions. In: PGRN Retreat, 3 - 4 November 2015, San Francisco, USA.

Phillips, E. (2014) Advances in antibiotic allergy. In: Infectious Diseases Grand Rounds, 24 July 2014, University of Melbourne (Austin Health).

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: 6th Drug Hypersensitivity Meeting (DHM6), 11 April 2014, Bern, Switzerland.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E. (2014) Specific binding characteristics of HLA alleles associate with Nevirapine hypersensitivity. In: Conference on Retroviruses and Opportunistic Infections (CROI) 2014, 3 - 6 March 2014, Boston, MA.

Phillips, E. (2014) Strategy and policy cohesion: "The one health agenda: will it deliver". In: Anti-microbial resistance: addressing the one health security agenda, Centre on Global Health Security at Chatham House, 9 December 2014, Murdoch University, Perth.

Villarino, M.E., Moro, R., Borisov, A., Adkinson, N.F., Phillips, E., Shepherd, G., Ho, C., Weis, S.E. and Sterling, T.R. (2013) Hypersensitivity reactions among persons receiving a 3 month regimen of rifapentine plus isoniazid for treatment of latent tuberculosis infection (LTBI). In: 20th Conference on Retroviruses and Opportunistic Infections (CROI) 2013, 3 - 6 March 2013, Atlanta, Georgia.

Phillips, E. (2013) Pharmacogenomics of drug hypersensitivity in HIV: Evolution of knowledge. In: 8th iSCAR Meeting, 16 - 18 November 2013, Taipei, Taiwan.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. In: 11th International Congress on Drug Therapy in HIV Infection, 11 - 15 November 2012, Glasgow, Scotland.

Lucas, A., Lucas, M., Pavlos, R., Mallal, S. and Phillips, E. (2012) Abacavir reactive HLA-B*5701 restricted memory CD8+ T cells are present in abacavir unexposed donors. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Bourke, J., Pavlos, R., Hollingsworth, P., McLean-Tooke, A., Horimoto, N., O'Brien, V., Edward, E. and Phillips, E. (2012) Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness. In: ASCIA 23rd Annual Scientific Meeting, 5 - 8 September 2012, Wellington, New Zealand.

Seet, J.M., Ingram, P.R., Lie, K., Phillips, E.J. and Murray, R.J. (2012) Using antibiotics better: The healthy antimicrobial prescribing initiative (HAPI). In: Australian Society for Antimicrobials 13th Annual Scientific Meeting, 23 - 25 February 2012, Brisbane Convention & Exhibition Centre, Brisbane.

Phillips, E., Keane, N., Blyth, C., Lucas, A., Pavlos, R., Lucas, M., McKinnon, E. and Mallal, S. (2011) Both HLA Class I restricted CD8+ and Class II restricted CD4+T Cells are implicated in the pathogenesis of nevirapine hypersensitivity. In: 51st Interscience Conference of Antimicrobial Agents and Chemotherapy, 17 - 20 September 2011, Chicago, IL.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J., Riadi, G., Mallal, S. and Jojic, N. (2011) HLA class I binding and its relationship with evolutionary conservation in human proteins and viral proteomes. In: Keystone HIV Evolution Genomics & Pathogenesis, 20 - 25 March 2011, Whistler, British Columbia, Canada.

Phillips, E. (2011) Immunogenetics and immunopathology of drug hypersensitivity. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Lucas, A.D., Lucas, M., Mallal, S. and Phillips, E.J. (2010) Antigen specific CD8+ T-cells in abacavir hypersensitivity are oligoclonal and CD34lo. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Phillips, E.J. and Mallal, S. (2010) Immunology of drug hypersensitivity reactions. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Phillips, E. (2010) The pharmacogenetics of drug hypersensitivity. In: WorldPharma 2010 – Bridging Basic and Clinical Pharmacology (16th World Congress of Basic & Clinical Pharmacology), 17 - 23 July 2010, Copenhagen, Denmark.

Lucas, A., Lucas, M., Mallal, S. and Phillips, E. (2010) Antigen specific CD8+T cells in abacavir hypersensitiviy can become oligoclonal, CD43Io+/-CD127hi. In: 40th Australasian Society of Immunology Annual Scientific Meeting, 5 - 9 December 2010, Perth, W.A.

McGettigan, B.D., McKinnon, E., Mallal, S., French, M., Hammond, E., Nolan, D. and Phillips, E.J. (2010) Association between low 25(OH) vitamin D levels, antiretroviral therapy and metabolic profile in a cohort of treated ahd therapy naive HIV positive patients in Western Australia. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Phillips, E., Lucas, M., Keane, N., Lucas, A., McKinnon, E. and Mallal, S. (2010) HLA-B*35 is associated with nevirapine hypersensitivity in the contemporary Western Australian HIV cohort study. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Phillips, E. (2009) Avoiding catastrophic drug toxicities: ‘Drugs that cause hypersensitivity reactions'. In: 2009 Annual Meeting of the American Association of Clinical Chemistry, 22 July 2009, Chicago, Illinois, USA.

Phillips, E. (2009) The pharmacogenetics of drug hypersensitivity: personalizing medicine and predicting the unpredictable? In: WAMSG Medication Safety Symposium, 14 July 2009, Perth, Australia.

Phillips, E. (2009) Human Genes and Adverse Drug Reactions: when genetics meets practical medicine needs: Pharmacogenetics and ADRs: a practical perspective. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute., 23 June 2009, Moscow, Russia.

Phillips, E.J. (2009) Drugs that cause hypersensitivity reactions: Personalising medicine & Predicting the unpredictable. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Phillips, E.J. (2009) Overcoming the barrier of clinical translation: The Abacavir example. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Phillips, E.J. (2009) Pharmacogenetic of drug hypersensitivity: Personalising medicine and predicting the unpredictable. In: WAMSG 5th Annual Medication Safety Symposium: ADRs ain'y just ADRs: Action on Adverse Drug Reactions for Medication Safety, 14 July 2009, University Club, University of Western Australia, Crawley.

Lee, M.H., Anderson, J., Stocker, S.L., Williams, K.M., Graham, G.G., Phillips, E.J., Nolan, D. and Day, R.O. (2009) A tale of two brothers: A familial study of risk factors to allopurinol-induced Stevens-Johnson Syndrome. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Mallal, S., Hertz, T., John, M., Gaudieri, S., James, I., Phillips, E., Nolan, D. and Jojic, N. (2008) Co-evolution of HLA and viruses: implications and applications. In: Australasian Society for Immunology Meeting, 7 - 11 December 2008, Canberra, ACT, Australia.

Khanam, T., Phillips, E., Lai, T. and Gong, G. (2008) Acetazolamide associated pulmonary oedema in a patient with prior exposure to hydrochlorothiazide. In: 4th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists, 22 - 26 November 2008, Melbourne, VIC.

Phillips, E., Nolan, D., Thorborn, D., Schaefer, M., Laird, R., Rauch, A., Rachlis, A., Shear, N., Knowles, S., Hughes, A., Montaner, J., James, I. and Mallal, S. (2008) Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals. In: 3rd International Drug Hypersensitivity Conference, 11 - 13 April 2008, Paris, France.

Nolan, D., Thorborn, D., Shaefer, M., Laird, R., Montaner, M., Hughes, A., James, I., Mallal, S. and Phillips, E. (2008) Genetic factors predicting abacavir hypersensitivty and tolerance in HLA-B*5701 positive individuals: Combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, U.S.A.

Rauch, A., Thurnheer, C., Fux, C., Nolan, D., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Genetic testing and structured clinical assessment reveal over diagnosis of abacavir hypersensitivity reactions in the Swiss HIV Cohort Study. In: 12th International Workshop on HIV Observational Databases, 27 - 30 March 2008, Malaga, Spain.

Wannamaker, P., Mallal, S., Phillips, E., Young, B., Brothers, C., Sutherland-Phillips, D., Thorborn, D. and Shaefer, M. (2008) HLA-B*5701 screening reduces abacavir hypersensitivity reactions (ABC HSR): Multiple lines of evidence to establish a new standard of care. In: 18th International AIDS Conference, 3 - 8 August 2008, Mexico City, Mexico.

Mallal, S., John, M., Gaudieri, S., Phillips, E. and Nolan, D. (2008) How might understanding of the co-evolution of HLA and viruses inform contemporary clinical issues. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Lo, G., Herrmann, S., Cheng, W., Kontorinis, N., Phillips, E., Nolan, D. and Lucas, M. (2008) Screening for hepatocellular carcinoma (HCC) in hepatitis/HIV co-infection using ultrasound imaging and alfa-feto protein levels. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Herrmann, S., McKinnon, E., John, M., Nolan, D., Martinez, O.P., Phillips, E. and Mallal, S. (2008) Side effects, dosing schedules, pill burden and perceived stress: Interaction and influence on medication adherence. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Chaubey, S., Sinha, A., Phillips, E., Russell, D. and Falhammar, H. (2008) Transient Sick Sinus Syndrome related to Lopinavir-Ritonavir in a patient with AIDS. In: 20th Annual Australasian Society of HIV Medicine Conference, 17 - 20 September 2008, Perth, Western Australia.

Mallal, S., Phillips, E., Carosi, G., Molina, J.M., Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kosyrey, O., Flores, C.J., Hay, P., Nolan, D., Thorborn, D. and Benbow, A. (2007) PREDICT-1: A novel randomized prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Phillips, E., Stasezewski, S., Arribas, J., Fitch, N. and Givens, N. (2007) Characteristics of abacavir hypersensitivity diagnoses according to HLA-B*5701 status and subsequent abacavir patch test result. In: 11th European AIDS Conference, 24 - 27 October 2007, Madrid, Spain.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Laird, R., Montaner, J., Shear, N., Lucas, A. and Mallal, S. (2007) Genetic characterization of patch test negative patients reporting symptoms after initiation after abacavir. In: 8th International Workshop on Clinical Pharmacology of HIV Therapy, 16 - 18 April 2007, Budapest, Hungary.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Cavassini, M., Harrigan, R., Montaner, J., Keane, N., Laird, R., Lucas, A. and Mallal, S. (2007) Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Saag, M., Balu, R., Brachman, P., Brothers, C., Stancil, B., Mosteller, M., Wannamaker, P., Sutherland‐Phillips, D., Phillips, E., Mallal, S. and Shaefer, M. (2007) High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically-confirmed cases of abacavir hypersensitivity (ABC HSR). In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Hammond, E., Almeida, C., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D.E., Chew, C.B., Neifer, S. and Mallal, S. (2007) Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Flores, C.J., Hay, P., Nolan, D., Hughes, S., Hughes, A., Thorborn, D. and Benbow, A. (2007) PREDICT-1: a novel randomised prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Hughes, S., Parry-Billings, K., Givens, N., Wong, D., Loeschel, E., Parada, P., Hughes, A., Curtis, L., Phillips, E. and Thorborn, D. (2007) Predict-1: A novel randomised prospective study to determine the clinical utility of prognostic screening for HLA-B*5701. In: Canadian Association for HIV Research Annual Meeting 2007, 26 - 29 April 2007, Ontario, Canada.

Keane, N., Lucas, A., Netto, J., Almeida, C., Martin, A., Marriott, D., Kelleher, A., Phillips, E., Nolan, D. and Mallal, S. (2007) Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Phillips, E. and Mallal, S. (2006) Predisposition to Drug Hypersensitivity in Patients with HIV. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E.J., Larsen, G., Brumme, Z., Harris, M., Toy, J., Harrigan, R., Mallal, S. and Montaner, J.S.G. (2006) Abacavir patch testing and rechallenge in patients labeled with abacavir hypersensitivity syndrome. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E., Yip, B., Hogg, R.S., Harrigan, R. and Montaner, J.S.G. (2006) Determinants and outcomes of nevirapine hypersensitivity. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Harris, N., Montaner, J.S.G. and Mallal, S. (2006) Pharmacogenetics and clinical characteristics of patch test confirmed patients with Abacavir hypersensitivity. In: 7th International Workshop on Clinical Pharmacology of HIV Therapy, 20 - 22 April 2006, Lisbon, Portugal.

Martin, A., Almeida, C., Nolan, D., Cameron, P., James, I., Purcell, T., McCluskey, J., Phillips, E. and Mallal, S. (2005) Abacavir stimulates Hsp70 redistribution in Antigen-presenting cells of patients with hypersensitivity: Association with Type-I alcohol dehydrogenase activity. In: 12th Conference on Retroviruses and Opportunistic Infections, 22 - 25 February 2005, Hynes Convention Center, Boston, MA.

Martin, A.M., Almeida, C., Nolan, D., Purcell, A., McCluskey, J., Phillips, E. and Mallal, S. (2005) Both the innate and adaptive immune systems are important in the pathogenesis of abacavir hypersensitivity reaction. In: Gordon Research Conference on Adverse Drug Reactions, 5 - 10 June 2005, New London, CT.

Phillips, E.J., Yip, B., Hogg, R.S. and Montaner, J.S.G. (2005) Determinants of and healthcare utilization associated with early discontinuation of abacavir: A case of genetic screening. In: 7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13 - 16 November 2005, Dublin, Ireland.

Phillips, E.J., Yip, B., Hogg, R.S. and Montaner, J.S.G. (2005) Determinants of and healthcare utilization associated with early discontinuation of abacavir: A case of genetic screening. In: 10th European AIDS Conference, 17 - 20 November 2005, Dublin, Ireland.

Harris, M., Alexander, C., Joy, R., Guillemi, S., Phillips, E., Langridge, S., Harrigan, R. and Montaner, J. (2005) Effect of atazanavir (ATZ) and ritonavir (RTV) plasma levels of increasing ATZ/rv daily dosing from 300/100mg to 300/200mg and 400/200mg. In: 6th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 April 2005, Quebec City, Quebec.

Christiansen, F.T., Martin, A.M., Nolan, D.A., Gaudieri, S., Almeida, C., Phillips, E., Cameron, P.U., Moore, C.B., James, I. and Mallal, S.A. (2005) Host MHC influences susceptibility to hypersensitivity reactions to two drugs commonly used in HIV therapy. In: XIX European Immunogenetics & Histocompatibility Conference, 23 - 26 April 2005, Istanbul, Turkey.

Martin, A.M., Almeida, C., Nolan, D., Cameron, P., Purcell, A., Chessman, D., McCluskey, J., Phillips, E. and Mallal, S. (2005) Involvement of metabolic and immune responses in the pathogenesis of Abacavir hypersensitivity reaction. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

Martin, A., Almeida, C., Purcell, A., McCluskey, J., Phillips, E. and Mallal, S. (2005) Pathogenesis of abacavir hypersensitivity mediated via stimulation of the innate and adaptive immune systems. In: Gordon Conference on Adverse Drug Reactions, 5 - 10 June 2005, Connecticut College, New London, CT.

Phillips, E. (2005) Using pharmacology in HIV practice: Challenges and strategies. In: 2nd Canadian Therapeutics Congress Joint Scientific Meeting, 13 - 19 April 2005, Vancouver, Canada.

Phillips, E., Alexander, C.S., Harris, M., Guillemi, S., Langridge, S., Scott, A. and Montaner, J. (2005) A retrospective review of protease-inhibitor based therapeutic drug monitoring in an HIV referral centre. In: 6th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 April 2005, Quebec City, Quebec.

Wong, G., Kaul, R., Shahabi, K., Nolan, D., Mallal, S., Knowles, S., Martin, A., Shear, N. and Phillips, E. (2004) Abacavir hypersensitivity syndrome: Results of clinical, immunological and genetic screening. In: 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 25 - 28 October 2004, Washington DC, U.S.A.

Martin, A., Cameron, P., Nolan, D., James, I., Keller, J., Phillips, E. and Mallal, S. (2004) Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*01 and higher CD4+ T cell counts. In: XV International AIDS Conference, 11 - 16 July 2004, Bangkok, Thailand.

Phillips, E., McGeer, A., Devlin, R., Khan, A., Loeb, M., Katic, M., Kiss, A. and Simor, A. (2004) Randomized controlled trial of combination therapy versus no treatment for the eradication of methicillin resistant Staphylococcus aureus (MRSA) colonization. In: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 30 October - 2 November 2004, Washington DC, U.S.A.

Cameron, M.J., Ran, L., Devries, M., Danesh, A., Persad, D., Xu, L., Bosinger, S.E., Cameron, C.M., Gold, W.L., Willey, B.M., Muller, M.P., Putanen, S.M., Louie, M., Phillips, E.J., Mederski, B.D., Keshavjee, S.H., Low, D.E., Loeb, M., McGeer, A.J. and Brunton, J. (2004) The human pathogenesis of SARS: Gene expression profiling of patients with severe acute respiratory syndrome (SARS). In: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 30 October - 2 November 2004, Washington DC, U.S.A.

Alexander, C., Montaner, J., Langridge, S., Guillemi, S., Harris, M., Phillips, E. and Harrigan, R. (2004) An interaction between atazanavir/ritonavir (ATV/RTV) and nevirapine (NVP) is observed in a clinical setting. In: 7th International Congress on Drug Therapy in HIV, 14 - 18 November 2004, Glasgow, Scotland.

van Heeswijk, R.P.G., Kahliq, Y., Gallicano, K., Bourbeau, M., Seguin, I., Phillips, E. and Cameron, B. (2004) The steady-state pharmacokinetics (PK) of nelfinavir (NFV) and M8 during pregnancy and postpartum. In: 5th International Workshop on Clinical Pharmacology of HIV Therapy, 1 - 3 April 2004, Rome, Italy.

Notman, M.J., Knowles, S.R., Phillips, E.J., Weber, E.A. and Shear, N.H. (2003) Ciprofloxacin skin testing: A retrospective study. In: American Academy of Allergy Asthma & Immunology (AAAAI) 60th Anniversary Meeting, 7 - 12 March 2003, Denver, CO.

Tailor, S., Knowles, S., Chen, J., Simor, A., Cornish, B., Cornish, P., Rachlis, A., Phillips, E., Gorenstein, F. and Ritchie, M. (2003) Development of a protocol to monitor for ototoxicity in patients receiving long-term aminoglycoside therapy. In: 34th Annual Professional Practice Conference. Canadian Society of Hospital Pharmacists, February 2003, Toronto, Canada.

Antoniou, T., Tseng, A., van Heeswijk, R., Giguère, P., Walker, S. and Phillips, E. (2003) Steady-state pharmacokinetics (PK) and tolerability of indinavir (IDV) when co-administered with lopinavir/ritonavir (LPV/r) in experienced subjects. In: 4th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 March 2003, Cannes, France.

Louie, M., Mazzulli, T., McGeer, A., Phillips, E., Loeb, M., Watt, C. and Simor, A.E. (2003) Transmission of methicillin-resistant Staphylococcus aureus (MRSA) to household contacts. In: SHEA 13th Annual Scientific Meeting, 5 - 8 April 2003, Arlington, Virginia.

Phillips, E., Saskin, R. and Raboud, J. (2003) The prevalence of hyperlipidemia in patients co-infected with hepatitis C and human immunodeficiency virus. In: 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 8 - 11 July, Paris, France.

Phillips, E., Raboud, J. and Saskin, R. (2003) A retrospective cohort study of liver toxicity in hepatitis B and C HIV co-infected patients in the HIV Ontario Observational Database. In: 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 8 - 11 July, Paris, France.

Phillips, E., Raboud, J. and Saskin, R. (2003) A retrospective cohort study of liver toxicity in hepatitis B and C HIV co-infected patients in the HIV Ontario observational database (HOOD). In: 2nd IAS Conference on HIV Pathogenesis and Treatment, 13 - 16 July 2003, Paris, France.

Knowles, S.R., Notman, M.J., Phillips, E.J., Weber, E.A. and Shear, N.H. (2003) The utility of skin testing in suspected clindamycin allergy. In: American Academy of Allergy Asthma & Immunology (AAAAI) 60th Anniversary Meeting, 7 - 12 March 2003, Denver, CO.

Phillips, E.J., Shear, N.H. and Knowles, S.R. (2002) Abacavir hypersensitivity syndrome: A new diagnostic test. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E., Knowles, S., Sullivan, J. and Shear, N. (2002) Abacavir hypersensitivity syndrome: A new diagnostic test. In: Canadian Infectious Disease Society Meeting, 1 March 2002, Banff, Alberta.

Phillips, E. (2002) Medication-induced syndromes and adverse drug reactions. In: 2002 North American Congress of Clinical Toxicology Annual Meeting, 24 - 29 September 2002, Palm Springs, California.

Phillips, E.J., Knowles, S.R. and Shear, N.H. (2002) Patch testing as a diagnostic modality in patients developing presumed drug-induced hypersensitivity syndromes on abacavir and Nonnucleoside Reverse Transcriptase Inhibitors (NRTIs). In: HIV DART 2002, 15 - 19 December 2002, Naples, Florida.

Phillips, E.J., Bayoumi, A.M., Raboud, J.M., Millson, P., Robinson, G. and Rachlis, A. (2002) Use of lipid-lowering drugs by patients receiving highly active antiretroviral therapy. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E.J., Bayoumi, A.M., Raboud, J.M., Millson, P., Robinson, G. and Rachlis, A. (2002) Use of lipid-lowering drugs by patients receiving highly active antiretroviral therapy. In: 11th Annual Canadian Conference on HIV/AIDS Research, 25 - 28 April 2002, Winnipeg, Manitoba.

Tseng, A., Loutfy, M., Phillips, E., Walker, S., Rachlis, A. and Walmsley, S. (2002) The relationship between lipid elevation and lopinavir (LPV) concentration in HIV-infected patients on LPV/r-containing salvage regimens. In: 42nd Annual ICAAC Meeting, 27 - 30 September 2002, San Diego, CA.

Phillips, E., Tseng, A., Loutfy, M., Walker, S., Tailor, S., Harrigan, R., Rachlis, A. and Walmsley, S. (2002) The use of virtual inhibitory quotient (VIQ) in antiretroviral (ART) experienced patients taking amprenavir/lopinavir combinations. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E., Tseng, A., Walker, S., Loutfy, M., Walmsley, S., Tailor, S. and Harrigan, P.R. (2002) The use of virtual inhibitory quotient (VIQ) in antiretroviral (ART) experienced patients taking amprenavir/lopinavir combinations. In: 9th Conference on Retroviruses and Opportunistic Infections, 24 - 28 February 2002, Seattle, U.S.A.

Phillips, E. (2001) Cost-effectiveness of therapeutic drug monitoring (TDM) of protease inhibitors (PI) in the treatment of HIV. In: 4th Annual Ontario HIV Treatment Netwrok Research Meeting, 10 November 2001, Ontario, Canada.

Phillips, E.J. and Rachlis, A.R. (2001) Digoxin toxicity and ritonavir: A drug interaction mediated through P-Glycoprotein? In: 2nd International Workshop on Clinical Pharmacology of HIV Therapy, 2 - 4 April 2001, Noordwijk, The Netherlands.

Risebrough, N. and Phillips, E.J. (2001) Potential cost effectiveness of therapeutic drug monitoring (TDM) of protease inhibitors in the treatment of HIV. In: 2nd International Workshop on Clinical Pharmacology of HIV Therapy, 2 - 4 April 2001, Noordwijk, The Netherlands.

Phillips, E.J., McGeer, A., Rotstein, C., Imrie, K. and Simor, A.E. (2000) Ambulatory treatment of febrile neutropenia (FN): A Canadian survey of current practice. In: 4th International Symposium on Febrile Neutropenia, 16 - 19 December 2000, Brussels, Belgium.

Phillips, E.J. (2000) Cutaneous drug reactions associated with antiretroviral drugs. In: Academy 2000: American Academy of Dermatology, 2 - 6 August 2000, Nashville, Tennessee.

Yeung, E., Phillips, E.J., Gardner, S., Leeb, K., Rachlis, A. and Shear, N. (2000) The impact of adverse drug events (ADEs) on subsequent therapy in patients initiating highly active antiretroviral therapy (HAART). In: Canadian Association for HIV Research Annual Meeting 2000, May 2000, Montreal, Quebec.

Phillips, E.J., Knowles, S.R., Shear, N.H. and Weber, E.A. (1999) Cross-reactivity between ampicillin and cephalexin in patients with isolated delayed skin test responses to ampicillin. In: 55th Annual Meeting of the American Academy of Allergy and Immunology, 26 February - March 3 1999, Orlando, FL.

Phillips, E.J., Knowles, S.R. and Shear, N.H. (1998) Allergic reactions to bisphosphonates. In: 67th Annual Meeting of the Royal College of Physicians and Surgeons of Canada, 24 - 27 September 1998, Toronto, Canada.

Phillips, E.J., Einarson, A., Mawji, F., D'Alimonte, D., Shick, B., Addis, A., Mazzone, T., Matsui, D. and Koren, G. (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. In: 67th Annual Meeting of the Royal College of Physicians and Surgeons of Canada, 24 - 27 September 1998, Toronto, Canada.

Phillips, E.J., Kumar, B., Oh, P.I., Shear, N.H., Sawka, C., Imrie, K. and Simor, A.E. (1997) Feasibility of outpatient treatment of febrile neutropenia at a Canadian tertiary care centre. In: 3rd International Symposium on Febrile Neutropenia, 10 - 13 December 1997, Brussels, Belgium.

Phillips, E.J., Ottaway, C.A., Freedman, J., Kardish, M., Li, J., Singer, W. and Fong, I.W. (1995) The effect of exercise on circulating lymphocyte redistribution in asymptomatic HIV-infected subjects. In: 2nd National Conference Human Retroviruses and Related Infections, 29 January - 3 February 1995, Washington DC, U.S.A.

Fong, I.W., Phillips, E.J., Kardish, M., Li, J. and Freedman, J. (1995) The effect of leucocyte function in patients with HIV infection. In: 2nd National Conference Human Retroviruses and Related Infections, 29 January - 3 February 1995, Washington DC, U.S.A.

Phillips, E.J., Willey, B.M., Kapur, V., Musser, J., Low, D.E. and McGeer, A. (1994) PCR-SSCP and automated DNA sequencing used to investigate a cluster of Pneumocystis carinii pneumonia (PCP). In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 4 - 7 October 1994, Orlando, FL.

Book Chapter

White, K., Gaudieri, S. and Phillips, E. (2014) HLA and pharmacogenetics of drug hypersensitivity. In: Padmanabhan, S., (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Academic Press, pp. 437-459.

Phillips, E.J. and Mallal, S.A. (2010) Abacavir. In: Wu, A.H.B. and Kiang-Teck, J.Y., (eds.) Pharmacogenomic Testing in Current Clinical Practice. Humana Press, New York, U.S.A, pp. 201-212.

Phillips, E.J. and Mallal, S.A. (2010) HLA and drug reactions. In: Mehra, N.K., Kaur, G., McCluskey, J., Christiansen, F.T. and Claas, F.H.J., (eds.) The HLA Complex in Biology and Medicine: A Resource Book. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 332-349.

Nolan, D., Almeida, C. and Phillips, E.J. (2007) Abacavir hypersensitivity. In: Pichler, W., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 116-125.

Nolan, D., Almeida, C., Phillips, E. and Mallal, S. (2007) Abacavir hypersensitivity. In: Pichler, W.J., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 95-104.

Nolan, D., Almeida, C. and Phillips, E. (2007) Abacavir hypersensitivity. In: Pichler, Werner J., (ed.) Drug Hypersensitivity. S.Karger AG, Basel, Switzerland.

Phillips, E.J., Uetrecht, J. and Walmsley, S.L. (2007) Antimicrobial agents that act on microbial cell wall formation. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 670-688.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Antimicrobial agents that affect the synthesis of cellular proteins. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 697-711.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Antimicrobial and antifungal agents that act on cell membranes. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 689-696.

Phillips, E.J., Uetrecht, J. and Walmsley, S.L. (2007) Drugs that affect cellular nucleic acid synthesis. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 712-723.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Principles of antimicrobial therapy. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 661-669.

Phillips, E., Feld, R. and McGeer, A. (1998) Infections in myeloma. In: Malpas, J.S., Bergsagel, D.E. and Kyle, R.A., (eds.) Myeloma: Biology and Management (2nd Ed.). Oxford University Press, New York, USA, pp. 439-476.

Phillips, E.J. and Keystone, J.S. (1997) Intestinal parasites. In: Rakel, R.E. and Kersey, R., (eds.) Conn's Current Therapy 1997: Latest. Saunders. An imprint of Elsevier, pp. 534-540.

Others

Phillips, E.J. (2000) Approach to hypersensitivity syndromes associated with antiretroviral agents. The PRN Notebook, 5 (4). pp. 14-17.

This list was generated on Tue Nov 21 06:05:04 2017 UTC.